Founded in 2010, Orpyx® Medical Technologies is a portfolio company of Western Economic Diversification and a global leader in telemedicine wound care solutions. Orpyx empowers people with diabetes to maintain mobility through its core product line, the Orpyx SI® Sensory Insole system. With the global headquarters based in Calgary, Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention-focused and sustainable in cost. Orpyx is ISO13485:2016 certified and holds both a Canadian Medical Device Establishment License (MDEL) and a Canadian Medical Device License (MDL).